[1] 蒋昵真,朱绍汶,汤心怡,等.256例ELISA筛查阴性/核酸检测无反应性标本的确认分析[J].中国输血杂志,2016,29(10):1126-1129.
[2] 杨瑞锋,樊春红.从“血清学阴性”HIV感染病例谈病毒抗体检测的局限性[J].临床检验杂志,2018,36(4):285-287.
[3] HALFON P,BOURLIÈRE M,PÉNARANDA G,et al.Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infection[J].J Clin Microbiol,2006,44(7):2507-2511.
[4] ROCHA D,ANDRADE E,GODOY D T,et al.The Brazilian experience of nucleic acid testing to detect human immunodeficiency virus,hepatitis C virus,and hepatitis B virus infections in blood donors[J].Transfusion,2018,58(4):862-870.
[5] RAIMONDO G,LOCARNINI S,POLLICINO T,et al.Update of the statements on biology and clinical impact of occult hepatitis B virus infection[J].J Hepatol,2019,71(2):397-408.
[6] 张毓,孙国栋,张丽,等.9例核酸反应性标本与对应ELISA、CLIA法检测HBV的关联分析[J].临床输血与检验,2018,20(2):206-208.
[7] 季阳,郑忠伟,蔡辉,等.病毒血清学检测与核酸检测技术在输血传染病筛检中的应用[J].中国输血杂志,2010,23(6):413-417.
[8] STRAMER S L,WEND U,CANDOTTI D,et al.Nucleic acid testing to detect HBV infection in blood donors[J].N Engl J Med,2011,364(3):236-247.
[9] KIANI I G,KHAN A N,BUTT B,et al.HCV-RNA pcr positivity in hcv antibody negative patients undergoing haemodialysis[J].J Ayub Med Coll Abbottabad,2018,30(3):397-400.
[10] AWAN S A,JUNAID A,SHEIKH S.Transfusion transmissible infections:maximizing donor surveil-lance[J].Cureus,2018,10(12):e3787.
[11] 孔祥沙,杨瑞锋,张海莹,等.北京大学人民医院2015年-2018年HCV感染筛查情况分析[J].临床肝胆病杂志,2019,35(8):1710-1713.
[12] MINE H,EMURA H,MIYAMOTO M,et al.High throughput screening of 16 million serologically negative blood donors for hepatitis B virus,hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan[J].J Virol Methods,2003,112(1/2):145-151.
[13] FIEDLER S A,OBERLE D,CHUDY M,et al.Effectiveness of blood donor screening by HIV,HCV,HBV-NAT assays,as well as HBsAg and anti-HBc immunoassays in Germany (2008-2015)[J].Vox Sang,2019,114(5):443-450.
[14] LAPERCHE S,TIBERGHIEN P,ROCHE-LONGIN C,et al.Fifteen years of nucleic acid testing in France:results and lessons[J].Transfus Clinique et Biol,2017,24(3):182-188.
[15] HOURFAR M K,JORK C,SCHOTTSTEDT V,et al.Experience of German Red Cross blood donor services with nucleic acid testing:results of screening more than 30 million blood donations for human immunodeficiency virus-1,hepatitis C virus,and hepatitis B virus[J].Transfusion,2008,48(8):1558-1566.
[16] 国家卫生健康委.国家卫生健康委关于印发血站技术操作规程(2019版)的通知[EB/OL].(2019-05-08).http://www.nhc.gov.cn/yzygj/s7658/201905/bdd4f4ccd15c4201bfb6d9e7492d7fab.shtml.
[17] 程金凤,焦巍,周红霞,等.术前/输血前患者乙型肝炎病毒、丙型肝炎病毒、人类免疫缺陷病毒核酸检测多中心研究[J].临床输血与检验,2020,22(6):568-573.
[18] 中华医学会感染病学分会,中华医学会肝病学分会.慢性乙型肝炎防治指南(2019年版)[J].中华传染病杂志,2019,37(12):711-736.
[19] 中华医学会肝病学分会,中华医学会感染病学分会.丙型肝炎防治指南(2019年版).中华肝脏病杂志,2019,27(12):962-979.
[20] 中华医学会感染病学分会艾滋病丙型肝炎学组,中国疾病预防控制中心.中国艾滋病诊疗指南(2018版)[J].国际流行病学传染病学杂志,2018,45(6):361-378.
[21] 中国疾病预防控制中心.《全国艾滋病检测技术规范(2020年修订版)》正式发布[EB/OL].(2020-05-18).http://ncaids.chinacdc.cn/zxzx/zxdteff/202005/t20200518_216798.htm.
[22] 中国医师协会检验医师分会分子诊断专家委员会.临床基因检验诊断报告模式专家共识[J].中华医学杂志,2016,96(14):1087-1090.
[23] 中华人民共和国国家卫生健康委员会.卫生部办公厅关于印发《医疗机构临床基因扩增管理办法》的通知[EB/OL].(2010-12-06).http://www.nhc.gov.cn/xxgk/pages/viewdocument.jsp?dispatchDate=&staticUrl=/zwgkzt/wsbysj/201012/49981.shtml. |
